GDP Forum

24/25 June 2020, Barcelona, Spain

Course No. 17226

header-image

Speakers

Cheryl Chia

Cheryl Chia

Lotus Phoenix Consulting

Dr Torsten Schmidt-Bader

Dr Torsten Schmidt-Bader

moveproTEC Compliance & Innovation Advisory

Emil Schwan

Emil Schwan

Swedish Medical Products Agency

Objectives

The aim of this conference is to inform about recent experiences made in the implementation of the EU GDP Guidelines. Challenges and possible solutions will be discussed and examples will demonstrate how the requirements can be put into practice.

Background

It is of key importance that medicinal products are not only made to a high quality in accordance with Good Manufacturing Practice (GMP), but that the quality and integrity of these products are maintained through the entire supply chain to the patient. This is where Good Distribution Practice (GDP) comes into Play.

In the last few years the world of GDP has changed in scope and complexity and continues to evolve to meet new challenges with the continued aim of safeguarding public health. The Falsified Medicines Directive (2011/62/EU) was transposed into the laws and regulations of the EU Member States alongside the introduction of revised EU guidelines on Good Distribution Practice. Many other countries followed adopting these Guidelines or implementing very similar approaches.

Target Group

All personnel involved in pharmaceutical storage, transportation, cold chain and distribution activities and the control of those activities.

Question and Answers Session

You will be able to send in GDP related questions before the conference. Additionally, questions can be posted on question cards during the conference.

Answers will be given by the expert speakers in a dedicated session and published in the members are of the GDP Association’s website (www.good-distribution-practice-group.org).

Programme

Performance beyond Compliance

  •  Benchmarks with sense
  •  When is a system or process robust?
  •  Easily understandable key figures
  •  Case studies

Brexit Implications

  •  Import/ export issues
  •  Drug shortage challenges
  •  Falsification
  •  Serialisation
  •  Co-operation of the agencies

GDP Challenges in Africa

  •  Background
  •  Evolution of GDP over the years
  •  Problems involved
  •  Steps taken to improve

Customer Master Data

  •  Definitions
  •  Parties involved
  •  Responsibilities and RP oversight
  •  Managing Customer Master Data
  •  Lifecycle Management

3 parallel Workshops:
1. Risk Management in GDP Warehousing

  •  Challenges and possible solutions
  •  Examples

2. When things go wrong – what can happen in the real World

  •  Experiences made in examining problems in the supply chain – and what to learn from them.

3. How to deal with suspected and confirmed falsified Medicines

  •  What is a suspected falsified medicine
  •  How to identify falsified medicine in your workplace
  •  How to approach the investigation of a suspected pack
  •  What should the end user do with the pack – who should manage communication with the end users

You will be able to attend TWO of these workshops. Please choose the ones you like to attend when you register.

Case Studies:
The Roche Quality Governance Model for Distribution to Direct Markets

  •  Selection, implementation, operation and decommissioning of partners
  •  Key Performance Indicators (KPIs)
  •  Compliance score card

The Switch from Air-freight to Sea-Freight

  •  Challenges and Benefits
  •  Examples

From external to internal Solutions - Insourcing of Warehousing and Logistics

  •  Implementation of own storage areas for minimum supply at the site
  •  Container and transport vehicle purchasing (refrigerated, warm, hazardous)

2 parallel Workshops:

1. Master Data and Serialisation

  •  Master Data for Serialisation
  •  Alerts Handling
  •  Exercises

2. Distribution of ATMPs

  •  Challenges when dealing with ATMP
  •  What information is needed to help service providers
  •  Examples

You will be able to attend ONE of these workshops. Please choose the one you like to attend when you register.

stop

This course is part of the GMP Certification Programme "ECA Certified GDP Compliance Manager" Learn more

ECA-Member*: € 1590,-
Non ECA Member*: € 1790,-
EU/GMP Inspectorates*: € 895,-
APIC Member Discount*: € 1690,-
GDP Association Member Discount*: € 1590,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023